Infliximab in inflammatory bowel disease

Anti-tumor necrosis factor (TNF) therapy has revolutionized the medical treatment of the inflammatory bowel diseases (IBD), Crohn’s disease (CD), and ulcerative colitis. Twenty years ago, infliximab became the first anti-TNF agent approved for IBD. Data from randomized controlled trials, large obser...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Ther Adv Chronic Dis
Huvudupphovsmän: Papamichael, Konstantinos, Lin, Steve, Moore, Matthew, Papaioannou, Garyfallia, Sattler, Lindsey, Cheifetz, Adam S.
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2019
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435871/
https://ncbi.nlm.nih.gov/pubmed/30937157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319838443
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk